Additional Submission Tools for Cosmetic Product Facility Registration and Product Listing

Recommendation
12/13 November 2025
How to implement EU-GMP Chapter 8
The FDA announced the availability of SPL Xforms, a Structured Product Labeling (SPL) authoring tool for cosmetic product facility registration and cosmetic product listing mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). This follows the recently announced launch of Cosmetics Direct, FDA's electronic submission portal.
Xforms is one option of creating an SPL file with cosmetic product facility registration and cosmetic product listing information. However, the agency is also accepting facility registrations and product listings via Cosmetics Direct and SPL-formatted submissions through the Electronic Submissions Gateway (ESG).
Furthermore, the FDA also announced the availability of Form FDA 5066 and Form FDA 5067 as an additional submission tool for providing cosmetic product facility registration and cosmetic product listing information to the agency. These paper forms are available at Registration & Listing of Cosmetic Product Facilities and Products.
While electronic submission is not required, the agency strongly encourages electronic submissions to facilitate efficiency and timeliness of data submission and management for the agency.
Related GMP News
28.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review
23.04.2025New WHO Guideline Package: TRS 1060 published
16.04.2025EMA: QPs must provide a written final Assessment and Approval of Third-Party Audit Reports
15.04.2025Strategic Report published by the Critical Medicines Alliance
09.04.2025EMA's Plans for the next three Years
09.04.2025Q&A Document on QP Declaration updated